Portrait of Andreas Struengmann & family

Rank #290

Andreas Struengmann & family

Net worth $11.1B

Pharmaceuticals · Germany

Born
Feb 16, 1950
Age
76
Source
Pharmaceuticals
Residence
Tegernsee
Citizenship
Germany
Marital status
Married
Children
2
Education
Medical Doctor, University at Buffalo

Net worth over time

Biography

  • Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.
  • The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.
  • The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.
  • In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.
  • After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa.

Financial assets

Exchange Ticker Company Shares Price Currency